To test the hypothesis that progressive endothelial dysfunction and loss of endothelial EPCR expression may underlie the observed reduction in sEPCR levels, age- and sex-matched patients with PAD stage III/IV were prospectively recruited. This evidence concerns the gene PROCR and peripheral arterial disease.